Muistisairaudet, näytönastekatsausten kirjallisuusviitteet

Kirjallisuutta

1. Aarsland D, Ballard C, Walker Z, ym. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2009;8(7):613-8 «PMID: 19520613»PubMed
2. AlDawsari A, Bushell TJ, Abutheraa N, ym. Use of sedative-hypnotic medications and risk of dementia: A systematic review and meta-analysis. Br J Clin Pharmacol 2022;88(4):1567-1589 «PMID: 34679196»PubMed
3. Baillon SF, Narayana U, Luxenberg JS, ym. Valproate preparations for agitation in dementia. Cochrane Database Syst Rev 2018;10(10):CD003945 «PMID: 30293233»PubMed
4. Bakchine S, Loft H. Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study. J Alzheimers Dis 2007;11(4):471-9 «PMID: 17656827»PubMed
5. Balbim GM, Falck RS, Barha CK, ym. Effects of exercise training on the cognitive function of older adults with different types of dementia: a systematic review and meta-analysis. Br J Sports Med 2022;(): «PMID: 35577539»PubMed
6. Ballard C, Hanney ML, Theodoulou M, ym. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009;8(2):151-7 «PMID: 19138567»PubMed
7. Barak Y, Plopski I, Tadger S, ym. Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study. Int Psychogeriatr 2011;23(9):1515-9 «PMID: 21492498»PubMed
8. Battle CE, Abdul-Rahim AH, Shenkin SD, ym. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Database Syst Rev 2021;2(2):CD013306 «PMID: 33704781»PubMed
9. Bergh S, Selbæk G, Engedal K. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial. BMJ 2012;344():e1566 «PMID: 22408266»PubMed
10. Bezabhe WM, Bereznicki LR, Radford J, ym. Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population-Based Cohort Study. J Am Heart Assoc 2022;11(7):e023098 «PMID: 35301852»PubMed
11. Bhattacharjee S, Patanwala AE, Lo-Ciganic WH, ym. Alzheimer's disease medication and risk of all-cause mortality and all-cause hospitalization: A retrospective cohort study. Alzheimers Dement (N Y) 2019;5():294-302 «PMID: 31338414»PubMed
12. Birks J, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev 2006;(1):CD001190 «PMID: 16437430»PubMed
13. Birks JS, Chong LY, Grimley Evans J. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev 2015;9(9):CD001191 «PMID: 26393402»PubMed
14. Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev 2018;6(6):CD001190 «PMID: 29923184»PubMed
15. Bond M, Rogers G, Peters J, ym. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technol Assess 2012;16(21):1-470 «PMID: 22541366»PubMed
16. Braz de Oliveira MP, Moreira Padovez RFC, Serrão PRMDS, ym. Effectiveness of physical exercise at improving functional capacity in older adults living with Alzheimer's disease: a systematic review of randomized controlled trials. Disabil Rehabil 2023;45(3):391-402 «PMID: 35171074»PubMed
17. Brodaty H, Aerts L, Harrison F, ym. Antipsychotic Deprescription for Older Adults in Long-term Care: The HALT Study. J Am Med Dir Assoc 2018;19(7):592-600.e7 «PMID: 29941156»PubMed
18. Bruun M, Koikkalainen J, Rhodius-Meester HFM, ym. Detecting frontotemporal dementia syndromes using MRI biomarkers. Neuroimage Clin 2019;22():101711 «PMID: 30743135»PubMed
19. Burckhardt M, Watzke S, Wienke A, ym. Souvenaid for Alzheimer's disease. Cochrane Database Syst Rev 2020;12(12):CD011679 «PMID: 33320335»PubMed
20. Burns A, Bernabei R, Bullock R, ym. Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial. Lancet Neurol 2009;8(1):39-47 «PMID: 19042161»PubMed
21. Cadogan SL, Powell E, Wing K, ym. Anticoagulant prescribing for atrial fibrillation and risk of incident dementia. Heart 2021;107(23):1898-1904 «PMID: 34645643»PubMed
22. Chan WC, Lam LC, Choy CN, ym. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 2001;16(12):1156-62 «PMID: 11748775»PubMed
23. Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet 2019;393(10170):407-415 «PMID: 30712900»PubMed
24. Cumbo E, Ligori LD. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial. J Alzheimers Dis 2014;39(3):477-85 «PMID: 24164733»PubMed
25. Cunningham EL, Todd SA, Passmore P, ym. Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2021;5(5):CD004034 «PMID: 34028812»PubMed
26. Davies RR, Kipps CM, Mitchell J, ym. Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol 2006;63(11):1627-31 «PMID: 17101833»PubMed
27. Davies RR, Scahill VL, Graham A, ym. Development of an MRI rating scale for multiple brain regions: comparison with volumetrics and with voxel-based morphometry. Neuroradiology 2009;51(8):491-503 «PMID: 19308367»PubMed
28. Davis KAS, Bishara D, Perera G, ym. Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta-Analysis. J Am Geriatr Soc 2020;68(3):650-658 «PMID: 32039479»PubMed
29. Declercq T, Petrovic M, Azermai M, ym. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev 2013;(3):CD007726 «PMID: 23543555»PubMed
30. Dementia: assessment, management and support for people living with dementia and their carers (NG97). NICE guideline Published 2018. «http://www.nice.org.uk/guidance/ng97»1
31. Devanand DP, Mintzer J, Schultz SK, ym. Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med 2012;367(16):1497-507 «PMID: 23075176»PubMed
32. Devanand DP, Pelton GH, Cunqueiro K, ym. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease. Int J Geriatr Psychiatry 2011;26(9):937-43 «PMID: 21845596»PubMed
33. Dubois B, Feldman HH, Jacova C, ym. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6(8):734-46 «PMID: 17616482»PubMed
34. Dubois B, Tolosa E, Katzenschlager R, ym. Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. Mov Disord 2012;27(10):1230-8 «PMID: 22915447»PubMed
35. Dudas R, Malouf R, McCleery J, ym. Antidepressants for treating depression in dementia. Cochrane Database Syst Rev 2018;8(8):CD003944 «PMID: 30168578»PubMed
36. Dysken MW, Sano M, Asthana S, ym. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 2014;311(1):33-44 «PMID: 24381967»PubMed
37. Eloniemi-Sulkava U, Saarenheimo M, Laakkonen ML, ym. Family care as collaboration: effectiveness of a multicomponent support program for elderly couples with dementia. Randomized controlled intervention study. J Am Geriatr Soc 2009;57(12):2200-8 «PMID: 20121986»PubMed
38. Emre M, Aarsland D, Albanese A, ym. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004;351(24):2509-18 «PMID: 15590953»PubMed
39. Emre M, Tsolaki M, Bonuccelli U, ym. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010;9(10):969-77 «PMID: 20729148»PubMed
40. Erkinjuntti T, Gauthier S, Bullock R, ym. Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6). J Psychopharmacol 2008;22(7):761-8 «PMID: 18308781»PubMed
41. Erkinjuntti T, Kurz A, Gauthier S, ym. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002;359(9314):1283-90 «PMID: 11965273»PubMed
42. European Medicines Agency. CHMP assessment report on conventional antipsychotics. EMEA/CHMP/590557/2008
43. Feldman H, Gauthier S, Hecker J, ym. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology 2001;57(4):613-20 «PMID: 11524468»PubMed
44. Feldman HH, Doody RS, Kivipelto M, ym. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology 2010;74(12):956-64 «PMID: 20200346»PubMed
45. Forbes D, Forbes SC, Blake CM, ym. Exercise programs for people with dementia. Cochrane Database Syst Rev 2015;2015(4):CD006489 «PMID: 25874613»PubMed
46. Forette F, Seux ML, Staessen JA, ym. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002;162(18):2046-52 «PMID: 12374512»PubMed
47. Freund-Levi Y, Jedenius E, Tysen-Bäckström AC, ym. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial. Am J Geriatr Psychiatry 2014;22(4):341-8 «PMID: 24035407»PubMed
48. Fumagalli GG, Gordon E, Harper L ym. 9th International Conference on Frontotemporal Dementias P.252 Development of a visual rating scale for atrophy of the anterior cingulate, insula and frontal lobes. Am J Neurodegener Dis 2014;3:1-375
49. Gray SL, Dublin S, Yu O, ym. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ 2016;352():i90 «PMID: 26837813»PubMed
50. Grossberg GT, Kohegyi E, Mergel V, ym. Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials. Am J Geriatr Psychiatry 2020;28(4):383-400 «PMID: 31708380»PubMed
51. Gu R, Gao Y, Zhang C, ym. Effect of Tai Chi on Cognitive Function among Older Adults with Cognitive Impairment: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2021;2021():6679153 «PMID: 34394392»PubMed
52. Haake A, Nguyen K, Friedman L, ym. An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease. Expert Opin Drug Saf 2020;19(2):147-157 «PMID: 31976781»PubMed
53. Hager K, Baseman AS, Nye JS, ym. Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease. Neuropsychiatr Dis Treat 2014;10():391-401 «PMID: 24591834»PubMed
54. Hampel H, Shaw LM, Aisen P, ym. State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease. Alzheimers Dement 2022;18(1):159-177 «PMID: 34043269»PubMed
55. Harper L, Fumagalli GG, Barkhof F, ym. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases. Brain 2016;139(Pt 4):1211-25 «PMID: 26936938»PubMed
56. He Y, Li H, Huang J, ym. Efficacy of antidepressant drugs in the treatment of depression in Alzheimer disease patients: A systematic review and network meta-analysis. J Psychopharmacol 2021;35(8):901-909 «PMID: 34238048»PubMed
57. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360(9326):7-22 «PMID: 12114036»PubMed
58. Hedderich DM, Dieckmeyer M, Andrisan T, ym. Normative brain volume reports may improve differential diagnosis of dementing neurodegenerative diseases in clinical practice. Eur Radiol 2020;30(5):2821-2829 «PMID: 32002640»PubMed
59. Hirsh Raccah B, Yanovsky A, Treves N, ym. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the risk for neurocognitive adverse events: A systematic review, meta-analysis and meta-regression. Int J Cardiol 2021;335():7-14 «PMID: 33892045»PubMed
60. Ho BL, Hsieh SW, Chou PS, ym. Effects of Dabigatran on Dementia Pathogenesis and Neuropsychological Function: A Review. J Alzheimers Dis 2022;86(4):1589-1601 «PMID: 35213379»PubMed
61. Holland P, Tappen R, Fisher L, Curtis AL. Effect of memantine on the progression of driving impairment in mild Alzheimer´s disease. Alzheimer´s & Dementia 2013; Conference: Alzheimer´s Association International Conference 2013 Boston, MA United States. Conference Start: 20120713 Conference End: 20130718. Conference Publication: P886-7
62. Homma A, Imai Y, Tago H, ym. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial. Dement Geriatr Cogn Disord 2008;25(5):399-407 «PMID: 18391486»PubMed
63. Howard R, McShane R, Lindesay J, ym. Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med 2012;366(10):893-903 «PMID: 22397651»PubMed
64. Hsu TW, Stubbs B, Liang CS, ym. Efficacy of serotonergic antidepressant treatment for the neuropsychiatric symptoms and agitation in dementia: A systematic review and meta-analysis. Ageing Res Rev 2021;69():101362 «PMID: 34000464»PubMed
65. Huang X, Zhao X, Li B, ym. Comparative efficacy of various exercise interventions on cognitive function in patients with mild cognitive impairment or dementia: A systematic review and network meta-analysis. J Sport Health Sci 2022;11(2):212-223 «PMID: 34004389»PubMed
66. Hughes D, Judge C, Murphy R, ym. Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis. JAMA 2020;323(19):1934-1944 «PMID: 32427305»PubMed
67. Imfeld P, Bodmer M, Jick SS, ym. Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis. Drug Saf 2015;38(10):909-19 «PMID: 26123874»PubMed
68. Islam MM, Iqbal U, Walther B, ym. Benzodiazepine Use and Risk of Dementia in the Elderly Population: A Systematic Review and Meta-Analysis. Neuroepidemiology 2016;47(3-4):181-191 «PMID: 28013304»PubMed
69. Janik MJ, Urbach DV, van Nieuwenhuizen E, ym. Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study. Atherosclerosis 2021;331():20-27 «PMID: 34303265»PubMed
70. Jiang D, Yang X, Li M, ym. Efficacy and safety of galantamine treatment for patients with Alzheimer's disease: a meta-analysis of randomized controlled trials. J Neural Transm (Vienna) 2015;122(8):1157-66 «PMID: 25547862»PubMed
71. Joe E, Ringman JM. Cognitive symptoms of Alzheimer's disease: clinical management and prevention. BMJ 2019;367():l6217 «PMID: 31810978»PubMed
72. Jones RW, Soininen H, Hager K, ym. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. Int J Geriatr Psychiatry 2004;19(1):58-67 «PMID: 14716700»PubMed
73. Kavanagh S, Van Baelen B, Schäuble B. Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective study. J Alzheimers Dis 2011;27(3):521-30 «PMID: 21891871»PubMed
74. Kipps CM, Davies RR, Mitchell J, ym. Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale. Dement Geriatr Cogn Disord 2007;23(5):334-42 «PMID: 17374952»PubMed
75. Kishi T, Sakuma K, Iwata N. Efficacy and Safety of Psychostimulants for Alzheimer's Disease: A Systematic Review and Meta-Analysis. Pharmacopsychiatry 2020;53(3):109-114 «PMID: 32000270»PubMed
76. Koedam EL, Lehmann M, van der Flier WM, ym. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol 2011;21(12):2618-25 «PMID: 21805370»PubMed
77. Lee SR, Choi EK, Park SH, ym. Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation. Stroke 2021;52(11):3459-3468 «PMID: 34496627»PubMed
78. Lehmann M, Koedam EL, Barnes J, ym. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiol Aging 2012;33(3):627.e1-627.e12 «PMID: 21596458»PubMed
79. Li DD, Zhang YH, Zhang W, ym. Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease. Front Neurosci 2019;13():472 «PMID: 31156366»PubMed
80. Li X, Guo R, Wei Z, ym. Effectiveness of Exercise Programs on Patients with Dementia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Biomed Res Int 2019;2019():2308475 «PMID: 31886182»PubMed
81. Lin M, Han W, Zhong J, ym. A systematic review and meta-analysis to determine the effect of oral anticoagulants on incidence of dementia in patients with atrial fibrillation. Int J Clin Pract 2021;75(10):e14269 «PMID: 33894031»PubMed
82. Liu L, Dong H, Jin X, ym. Tackling Dementia: A Systematic Review of Interventions Based on Physical Activity. J Geriatr Phys Ther 2022;45(4):E169-E180 «PMID: 34570041»PubMed
83. Livingston G, Huntley J, Sommerlad A, ym. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020;396(10248):413-446 «PMID: 32738937»PubMed
84. Lonergan E, Luxenberg J, Colford J. Haloperidol for agitation in dementia. Cochrane Database Syst Rev 2002;(2):CD002852 «PMID: 12076456»PubMed
85. Loveman E, Green C, Kirby J, ym. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. Health Technol Assess 2006;10(1):iii-iv, ix-xi, 1-160 «PMID: 16409879»PubMed
86. Maidment I, Fox C, Boustani M. Cholinesterase inhibitors for Parkinson's disease dementia. Cochrane Database Syst Rev 2006;(1):CD004747 «PMID: 16437494»PubMed
87. Matsunaga S, Kishi T, Iwata N. Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: a systematic review and meta-analysis. Int J Neuropsychopharmacol 2014;18(5): «PMID: 25548104»PubMed
88. Mattsson N, Lönneborg A, Boccardi M, ym. Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiol Aging 2017;52():196-213 «PMID: 28317649»PubMed
89. Maust DT, Kim HM, Seyfried LS, ym. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry 2015;72(5):438-45 «PMID: 25786075»PubMed
90. McKeith I, Del Ser T, Spano P, ym. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000;356(9247):2031-6 «PMID: 11145488»PubMed
91. McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev 2006;(2):CD003154 «PMID: 16625572»PubMed
92. McShane R, Westby MJ, Roberts E, ym. Memantine for dementia. Cochrane Database Syst Rev 2019;3(3):CD003154 «PMID: 30891742»PubMed
93. Mefford MT, Rosenson RS, Cushman M, ym. PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS). Circulation 2018;137(12):1260-1269 «PMID: 29146683»PubMed
94. Michalowsky B, Xie F, Eichler T, ym. Cost-effectiveness of a collaborative dementia care management-Results of a cluster-randomized controlled trial. Alzheimers Dement 2019;15(10):1296-1308 «PMID: 31409541»PubMed
95. Mintzer J, Lanctôt KL, Scherer RW, ym. Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial. JAMA Neurol 2021;78(11):1324-1332 «PMID: 34570180»PubMed
96. Mohs RC, Doody RS, Morris JC, ym. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology 2001;57(3):481-8 «PMID: 11502917»PubMed
97. Mori E, Ikeda M, Kosaka K, ym. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol 2012;72(1):41-52 «PMID: 22829268»PubMed
98. Mueller C, Perera G, Hayes RD, ym. Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis. Age Ageing 2018;47(1):88-94 «PMID: 28655175»PubMed
99. Muldoon MF, Ryan CM, Sereika SM, ym. Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am J Med 2004;117(11):823-9 «PMID: 15589485»PubMed
100. Musiek ES, Holtzman DM. Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science 2016;354(6315):1004-1008 «PMID: 27885006»PubMed
101. Mühlbauer V, Möhler R, Dichter MN, ym. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev 2021;12(12):CD013304 «PMID: 34918337»PubMed
102. Nakano Y, Matsuzono K, Yamashita T, ym. Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS). J Alzheimers Dis 2015;47(3):609-17 «PMID: 26401696»PubMed
103. NICE. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (TA217). NICE 2022. Published: 23 March 2011. Last updated 20 June 2018. «https://www.nice.org.uk/guidance/ta217»2
104. Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study. Br J Psychiatry 1990;157():894-901 «PMID: 1705151»PubMed
105. Ogunwale AN, Colon-Emeric CS, Sloane R, ym. Acetylcholinesterase Inhibitors Are Associated with Reduced Fracture Risk among Older Veterans with Dementia. J Bone Miner Res 2020;35(3):440-445 «PMID: 31711264»PubMed
106. Olmastroni E, Molari G, De Beni N, ym. Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies. Eur J Prev Cardiol 2022;29(5):804-814 «PMID: 34871380»PubMed
107. Olsson B, Lautner R, Andreasson U, ym. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. Lancet Neurol 2016;15(7):673-684 «PMID: 27068280»PubMed
108. Osler M, Jørgensen MB. Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders: A Nationwide Cohort and Nested Case-Control Study. Am J Psychiatry 2020;177(6):497-505 «PMID: 32252539»PubMed
109. Ou YN, Tan CC, Shen XN, ym. Blood Pressure and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 209 Prospective Studies. Hypertension 2020;76(1):217-225 «PMID: 32450739»PubMed
110. Pemberton HG, Goodkin O, Prados F, ym. Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study. Eur Radiol 2021;31(7):5312-5323 «PMID: 33452627»PubMed
111. Pemberton HG, Zaki LAM, Goodkin O, ym. Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis-a systematic review. Neuroradiology 2021;63(11):1773-1789 «PMID: 34476511»PubMed
112. Peskind ER, Potkin SG, Pomara N, ym. Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Am J Geriatr Psychiatry 2006;14(8):704-15 «PMID: 16861375»PubMed
113. Pitkälä KH, Pöysti MM, Laakkonen ML, ym. Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial. JAMA Intern Med 2013;173(10):894-901 «PMID: 23589097»PubMed
114. Pollock BG, Mulsant BH, Rosen J, ym. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry 2002;159(3):460-5 «PMID: 11870012»PubMed
115. Porsteinsson AP, Drye LT, Pollock BG, ym. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA 2014;311(7):682-91 «PMID: 24549548»PubMed
116. Porsteinsson AP, Grossberg GT, Mintzer J, ym. Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. Curr Alzheimer Res 2008;5(1):83-9 «PMID: 18288936»PubMed
117. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005;4(8):487-99 «PMID: 16033691»PubMed
118. Rasmussen J. The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer's disease? Clin Interv Aging 2019;14():1481-1492 «PMID: 31616139»PubMed
119. Rege S, Carnahan RM, Johnson ML, ym. Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study. Drugs Aging 2021;38(6):493-502 «PMID: 33763822»PubMed
120. Rivard L, Friberg L, Conen D, ym. Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. Circulation 2022;145(5):392-409 «PMID: 35100023»PubMed
121. Rivard L, Khairy P, Talajic M, ym. Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design. Can J Cardiol 2019;35(8):1069-1077 «PMID: 31376908»PubMed
122. Rogers SL, Farlow MR, Doody RS, ym. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology 1998;50(1):136-45 «PMID: 9443470»PubMed
123. Rolinski M, Fox C, Maidment I, ym. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev 2012;2012(3):CD006504 «PMID: 22419314»PubMed
124. Russ TC, Morling JR. Cholinesterase inhibitors for mild cognitive impairment. Cochrane Database Syst Rev 2012;2012(9):CD009132 «PMID: 22972133»PubMed
125. Ruths S, Straand J, Nygaard HA, ym. Effect of antipsychotic withdrawal on behavior and sleep/wake activity in nursing home residents with dementia: a randomized, placebo-controlled, double-blinded study. The Bergen District Nursing Home Study. J Am Geriatr Soc 2004;52(10):1737-43 «PMID: 15450054»PubMed
126. Savela S, Komulainen P, Sipilä S, Strandberg T. Ikääntyneiden liikunta - minkälaista ja mihin tarkoitukseen? Duodecim 2015;131:1719-25
127. Scheltens P, Leys D, Barkhof F, ym. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55(10):967-72 «PMID: 1431963»PubMed
128. Scheltens P, Twisk JW, Blesa R, ym. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis 2012;31(1):225-36 «PMID: 22766770»PubMed
129. Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006;14(3):191-210 «PMID: 16505124»PubMed
130. Schneider LS, Frangakis C, Drye LT, ym. Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial. Am J Psychiatry 2016;173(5):465-72 «PMID: 26771737»PubMed
131. Shah RC, Kamphuis PJ, Leurgans S, ym. The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease. Alzheimers Res Ther 2013;5(6):59 «PMID: 24280255»PubMed
132. Shash D, Kurth T, Bertrand M, ym. Benzodiazepine, psychotropic medication, and dementia: A population-based cohort study. Alzheimers Dement 2016;12(5):604-13 «PMID: 26602630»PubMed
133. Shaw LM, Arias J, Blennow K, ym. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease. Alzheimers Dement 2018;14(11):1505-1521 «PMID: 30316776»PubMed
134. Shepherd J, Blauw GJ, Murphy MB, ym. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360(9346):1623-30 «PMID: 12457784»PubMed
135. Shim Y, Yoon B, Na S, ym. A systematic review and meta-analysis of the clinical effects of Souvenaid in patients with Alzheimer's disease. Asia Pac J Clin Nutr 2021;30(1):30-41 «PMID: 33787038»PubMed
136. Siddique H, Hynan LS, Weiner MF. Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease. J Clin Psychiatry 2009;70(6):915-8 «PMID: 19422762»PubMed
137. Soininen H, Solomon A, Visser PJ, ym. 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial. Lancet Neurol 2017;16(12):965-975 «PMID: 29097166»PubMed
138. Soininen H, Solomon A, Visser PJ, ym. 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease. Alzheimers Dement 2021;17(1):29-40 «PMID: 32920957»PubMed
139. SPRINT MIND Investigators for the SPRINT Research Group, Williamson JD, Pajewski NM, ym. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA 2019;321(6):553-561 «PMID: 30688979»PubMed
140. SPRINT Research Group, Wright JT Jr, Williamson JD, ym. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2015;373(22):2103-16 «PMID: 26551272»PubMed
141. Strandberg TE, Benetos A, Petrovic M. Editorial: Incident Dementia in Trials of Antihypertensive Treatments. J Nutr Health Aging 2019;23(10):914-915 «PMID: 31781718»PubMed
142. Ströhle A, Schmidt DK, Schultz F, ym. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials. Am J Geriatr Psychiatry 2015;23(12):1234-1249 «PMID: 26601726»PubMed
143. Summers MJ, Oliver KR, Coombes JS, ym. Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) trial. Pharmacotherapy 2007;27(2):183-90 «PMID: 17253908»PubMed
144. Tam-Tham H, Cepoiu-Martin M, Ronksley PE, ym. Dementia case management and risk of long-term care placement: a systematic review and meta-analysis. Int J Geriatr Psychiatry 2013;28(9):889-902 «PMID: 23188735»PubMed
145. Tan CC, Yu JT, Wang HF, ym. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 2014;41(2):615-31 «PMID: 24662102»PubMed
146. Tan L, Tan L, Wang HF, ym. Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis. Alzheimers Res Ther 2015;7(1):20 «PMID: 25897331»PubMed
147. Taylor BA, Dager AD, Panza GA, ym. The effect of high-dose atorvastatin on neural activity and cognitive function. Am Heart J 2018;197():166-174 «PMID: 29447778»PubMed
148. U.S. Food and Drug Administration. Postmarket Drug Safety Information for Patients and Providers
149. Van Leeuwen E, Petrovic M, van Driel ML, ym. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev 2018;3(3):CD007726 «PMID: 29605970»PubMed
150. Venegas-Sanabria LC, Cavero-Redondo I, Martínez-Vizcaino V, ym. Effect of multicomponent exercise in cognitive impairment: a systematic review and meta-analysis. BMC Geriatr 2022;22(1):617 «PMID: 35879665»PubMed
151. Veroniki AA, Ashoor HM, Rios P, ym. Comparative safety and efficacy of cognitive enhancers for Alzheimer's dementia: a systematic review with individual patient data network meta-analysis. BMJ Open 2022;12(4):e053012 «PMID: 35473731»PubMed
152. Waldemar G, Gauthier S, Jones R, ym. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease. Int J Geriatr Psychiatry 2011;26(2):150-7 «PMID: 20597141»PubMed
153. Wattjes MP, Henneman WJ, van der Flier WM, ym. Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology 2009;253(1):174-83 «PMID: 19635835»PubMed
154. Weintraub D, Drye LT, Porsteinsson AP, ym. Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease. Am J Geriatr Psychiatry 2015;23(11):1127-33 «PMID: 26238225»PubMed
155. Wilcock G, Howe I, Coles H, ym. A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease. Drugs Aging 2003;20(10):777-89 «PMID: 12875613»PubMed
156. Wild R, Pettit T, Burns A. Cholinesterase inhibitors for dementia with Lewy bodies. Cochrane Database Syst Rev 2003;2003(3):CD003672 «PMID: 12917981»PubMed
157. Winblad B, Engedal K, Soininen H, ym. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001;57(3):489-95 «PMID: 11502918»PubMed
158. Xie L, Kang H, Xu Q, ym. Sleep drives metabolite clearance from the adult brain. Science 2013;342(6156):373-7 «PMID: 24136970»PubMed
159. Yeh SW, Lin LF, Chen HC, ym. High-intensity functional exercise in older adults with dementia: A systematic review and meta-analysis. Clin Rehabil 2021;35(2):169-181 «PMID: 33040592»PubMed
160. Yeh TC, Tzeng NS, Li JC, ym. Mortality Risk of Atypical Antipsychotics for Behavioral and Psychological Symptoms of Dementia: A Meta-Analysis, Meta-Regression, and Trial Sequential Analysis of Randomized Controlled Trials. J Clin Psychopharmacol 2019;39(5):472-478 «PMID: 31433335»PubMed
161. Yu JT, Xu W, Tan CC, ym. Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry 2020;91(11):1201-1209 «PMID: 32690803»PubMed
162. Yunusa I, Alsumali A, Garba AE, ym. Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis. JAMA Netw Open 2019;2(3):e190828 «PMID: 30901041»PubMed
163. Yunusa I, Rashid N, Abler V, ym. Comparative Efficacy, Safety, Tolerability, and Effectiveness of Antipsychotics in The Treatment of Dementia-Related Psychosis (DRP): A Systematic Literature Review. J Prev Alzheimers Dis 2021;8(4):520-533 «PMID: 34585228»PubMed
164. Zetterberg H. Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature. Alzheimers Dement 2022;18(9):1687-1693 «PMID: 35213777»PubMed
165. Zhong G, Wang Y, Zhang Y, ym. Association between Benzodiazepine Use and Dementia: A Meta-Analysis. PLoS One 2015;10(5):e0127836 «PMID: 26016483»PubMed
166. Öhman H, Savikko N, Strandberg TE, ym. Effects of Exercise on Cognition: The Finnish Alzheimer Disease Exercise Trial: A Randomized, Controlled Trial. J Am Geriatr Soc 2016;64(4):731-8 «PMID: 27037872»PubMed